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Abstract
Introduction: Acceptability and willingness to both take and pay for HIV self-tests (HIVSTs) in US neighbourhoods with high
rates of HIV infection are not well understood.
Methods: We surveyed 1,535 individuals about acceptability and willingness to take and pay for an HIVST in a predominately
African American neighbourhood with 3% HIV seroprevalence. We recruited individuals presenting for HIV screening services
in a community-based programme. Latent class analysis (LCA) grouped individuals with similar patterns of HIV-risk behaviours
and determined which groups would be most willing to use and buy HIVSTs.
Results: Nearly 90% of respondents were willing to use an HIVST; 55% were willing to buy HIVSTs, but only 23% were willing
to pay the market price of US $40. Four distinct groups emerged and were characterized by risk behaviours: (1) low risk
(N = 324); (2) concurrent partnerships (N = 346); (3) incarceration and substance use (N = 293); and (4) condomless sex/
multiple partners (N = 538). Individuals in the low-risk class were less willing to self-test compared to concurrent sexual
partners (OR = 0.39, p = .003) and incarceration and substance use (OR = 0.46, p = .011) classes. There were no significant
differences across classes in the amount individuals were willing to pay for an HIVST.
Conclusions: HIVSTs were overwhelmingly acceptable but cost prohibitive; most participants were unwilling to pay the
market rate of US $40. Subsidizing and implementing HIVST programmes in communities with high rates of infection present
a public health opportunity, particularly among individuals reporting condomless sex with multiple partners, concurrent
sexual partnerships and those with incarceration and substance use histories.
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Introduction
Approximately 1.2 million Americans are living with HIV
[1,2]. HIV testing is a critical gateway to HIV/AIDS treatment
and care. Nationwide, 13% of HIV-infected people are una-
ware of their infection [3]. Individuals unaware of their HIV
infection contribute to nearly 50% of new HIV transmissions
in the United States (US) [4]. Since 2006, the Centers for
Disease Control and Prevention (CDC) has recommended
that all adults between the ages of 13 and 65 be tested for
HIV at least once annually, and that HIV screening be con-
ducted routinely in clinical settings [5]. However, only 54%
of Americans have ever undergone HIV screening, and only
22% of all Americans have been tested in the past year [6].
Many individuals at high risk for contracting HIV still do
not have access to clinical HIV screening services [7,8]. Racial
and ethnic minorities and individuals from lower socio-eco-
nomic strata are less likely to be aware of their HIV infection
[9,10]. African Americans and Hispanics/Latinos have eight
and three times the infection rates of Whites [11], are more
likely to present for care late in the course of their infection
[12], and have poorer outcomes at every point along the HIV
care continuum [13,14]. Additionally, African Americans and
Hispanics are more likely to live in urban neighbourhoods
with high levels of concentrated poverty and structural and
social barriers that may prohibit access to healthcare ser-
vices, and HIV testing and care [15].
One potential opportunity to expand HIV screening to
populations with limited access to HIV screening and care
services, and particularly urban communities of colour, is
through HIV self-tests (HIVSTs) [9,16,17]. In July 2012, the
US Food and Drug Administration approved the “OraQuick®
In-Home HIV Test” – the first over-the-counter, HIVST [18].
The HIVST retails for approximately US $40 in pharmacies
and provides results in 20 minutes; individuals with reactive
results are instructed to see a medical professional for
confirmatory testing and care.
HIVSTs provide an opportunity to expand HIV testing in
urban communities. Many groups with high HIV infection
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rates have limited healthcare infrastructure; therefore,
HIVSTs might fill unmet needs for screening [9,19].
Moreover, HIVSTs may be particularly important in commu-
nities of colour with high rates of stigma; HIVSTs can also
provide opportunities for individuals to self-test who would
prefer not to test in clinical settings [20–22]. While HIVSTs
have the potential to help reduce disparities in HIV screen-
ing, treatment and care, HIVST acceptability has not been
well explored in urban communities of colour with high HIV
infection rates.
Little is known about acceptability or affordability of
HIVSTs, particularly in the most heavily impacted urban
neighbourhoods in the US and among individuals at highest
risk for acquiring HIV [9]. One recent study found that
knowledge related to HIV transmission, treatment and con-
cern about HIV in an individual’s community was associated
with willingness to use an HIVST [23]. Another study sug-
gested the retail price of the HIVSTs was too high – with
most people preferring a price closer to US $22 [24]. In
addition, a study among transwomen in San Francisco
found that most were willing to use HIVSTs, but that price
was a critical determinant of whether or not they would
actually use them. Participants relayed that cost was the
biggest barrier to using HIVSTs but that they would be
willing to pay as much as $US $20 [25].
The current study is based on a geographically-focused,
community-based, HIV and hepatitis C (HCV) testing, treat-
ment and retention-in-care implementation research pro-
gramme in a predominately African American
neighbourhood in Philadelphia, Pennsylvania (PA) with
2–3% HIV seroprevalence and limited access to HIV screen-
ing and care services [26]. In an effort to expand HIV
screening and care services in this urban community, this
programme combined social marketing and community
mobilization, door-to-door HIV and HCV outreach, and
screening in non-clinical and clinical settings; the results
of the screening and linkage to care programme have
been presented elsewhere [17,27,28]. Among participants
in the programme, we explored acceptability, affordability
and attitudes about purchasing HIVSTs among participants.
Methods
We collected information about attitudes related to HIVSTs
as well as willingness to pay for HIVSTs among individuals
who presented for HIV and HCV screening services on a
mobile medical unit in urban Philadelphia between
December 2012 and January 2014. Trained HIV/HCV testers
conducted surveys face-to-face in a private room. Survey
answers were recorded on encrypted tablets using IllumeTM
software (Datstat, Washington). Participants did not receive
monetary compensation, but received free HIV and HCV
testing, linkage to care services and HIV and HCV treatment
when necessary. All participants provided informed con-
sent. The Miriam Hospital institutional review board
approved this study.
The survey included questions about demographic, beha-
vioural, structural, and social factors, including information
on sexual partners and risk behaviours, and HIV and HCV
testing history. Specific questions about HIVSTs explored
whether participants would use an HIVST, whether they
thought that their friends and family would use a self-
test, how much participants would be willing to pay for
an HIVST, and whether they would go to a doctor if the
HIVST result were reactive.
Measures
Participant demographic covariates included age (separated
into four ordinal age categories: twenty years old or
younger, 21–30, 31–39 and 40 or older), sex, education
(less than a high school degree, high school degree and at
least some college education), sexual orientation (straight,
gay/lesbian or bisexual), how often the participant
attended religious services (never, sometimes, at least
once a week), employment status (full/part time or unem-
ployed), and whether or not the participant had medical
insurance or a primary care physician.
A total of 12 variables (hereafter called classification
variables) were included in the latent class analysis (LCA)
to identify latent classes of individuals. These classification
variables were selected to represent a range of established
HIV risk factors in order to identify comprehensive HIV-risk
profiles. They included measures of incarceration history,
perceived HIV risk, prior HIV testing, sexual behaviour and
substance use. The survey assessed incarceration history by
asking participants whether they had ever been incarcer-
ated (yes or no). Perceived HIV risk was assessed by asking
participants to rate their risk for HIV on a four-point Likert
scale ranging from “not at risk” to “high risk”. Responses on
this variable were dichotomized into “moderate to high
risk” and “low to no risk”. Participants were also asked
whether they had ever been screened for HIV (yes or no).
Sexual behaviour was assessed by asking participants
whether they had engaged in condomless sex (anal, vaginal,
oral) within the past year (yes or no); whether, in the past
year, they had engaged in condomless sex in exchange for
drugs, alcohol, gifts, food, or shelter; and if they had ever
had sex with someone who was HIV positive or someone
with a history of injection drug use. Participants who
responded yes to at least one of these questions were
coded as having engaged in higher-risk sexual encounters.
Participants were also asked whether they had engaged in
concurrent sexual partnerships, defined as whether they
were engaged in sexual partnerships that overlapped in
time (yes or no). They were also asked the number of
partners they had in the past year (0–1, 2–5, 6 or more)
and whether they believed their most recent partner had
concurrent sexual partners during the time period they
were also in a sexual partnership (yes or no).
Substance use was measured with a number of questions
related to drug and alcohol use. Questions included: how
often have you had six or more drinks on one occasion
(coded as less than monthly vs. monthly or more), and
binary variables asking did you drink alcohol the last time
you had sex (yes or no), have you ever used crack, cocaine,
heroin, prescription drugs without a prescription, ecstasy,
special K or crystal methamphetamine (yes or no).
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HIVST outcomes were assessed by asking questions
related to participants’ attitudes about and willingness to
buy HIVSTs. To assess attitudes, two questions were asked:
(1) how likely are you to take an HIVST if it was provided for
free, and (2) how likely are you to buy an HIVST. Both
questions originally had a five-point Likert response scale
(very unlikely, unlikely, neutral, likely and very likely) but
were transformed into a binary variable for analysis –
“likely”, which included likely and very likely, vs. “not
likely”, which included “neutral”, “unlikely” and “very unli-
kely”. To assess willingness to buy an HIVST, participants
were asked how much they would be willing to pay for an
HIVST at their local pharmacy. Response options included
“not interested in buying a test”, $0–10, $11–20, $21–30,
$31–40, or $40 or more. A binary variable was created in
which all price variables other than $40 or more were
combined and coded as 0, and $40 or more was coded as
1 to understand whether participants would be willing to
pay $40 or more (the approximate retail value of an HIVST)
or less.
Data analysis
LCA was used to identify classes based on perceived HIV
risk, HIVST history, past incarceration, sexual behaviour and
substance-use variables. Classes are considered latent
because class membership is not directly observed; rather
it is inferred (probabilistically) based on an individual’s
pattern of responses across a set of variables (i.e. their
response profile). Unlike traditional regression analyses,
LCA provides a multidimensional perspective that shows
how variables work together to predict multiple HIVST out-
comes such as HIVST uptake, likeliness to pay, and payment
thresholds. Using LCA to discover underlying groups of
individuals with similar risk response profiles allowed us
to identify which kinds of group profiles would be most
likely to both use and pay for HIVSTs. This method differs
from multivariate analyses that examine the independent
association of each variable with the response variable
while holding other variables constant at a certain value.
In other words, by identifying groups of individuals that
share similar response profiles on the 12 classification vari-
ables, LCA provides information on how multiple variables
interact with each other to predict response variables. This
differs from traditional regression methods that would
require a large number of interaction terms, which in
turn, can make a regression model unwieldy and challen-
ging to interpret.
A series of LCA models specifying 1–6 latent classes were
tested using the Mplus software package [29]. To avoid the
likelihood of converging on a local maximum, 500 start
values were generated for each model. Indices used to
determine the optimal LCA solution included the sample
size-adjusted Bayesian Information Criterion (BIC) and the
adjusted Lo Mendell Rubin (LMR) likelihood ratio test for
model fit which tests the null hypothesis of no improve-
ment in fit for the model under consideration compared to
a model with one less class. Entropy, which measures the
extent to which classes are distinct from one another, the
average posterior probability of class membership, and the
interpretability of the classes, was also considered. Logistic
regression (for binary classification variables) and multino-
mial logistic regression (for categorical classification vari-
ables) were used to test for significant differences between
classes on the latent class classification variables.
After identifying the LCA model with the number of classes
that had the optimal LCA solution based on the criteria above,
we added the participant demographic characteristics (age,
gender, education, sexual orientation, religious services atten-
dance, employment, medical insurance and primary care phy-
sician) to this model as covariates. In addition, we included
the two outcome variables measuring likelihood of taking and
buying an HIVST. We did not include amount willing to pay for
an HIVST because it represented only the portion of the
sample that indicated interest in buying an HIVST. We did
not include race as a covariate because 89% of the sample was
African American. However, we conducted a secondary multi-
nomial logistic regression analysis, adjusting for the covari-
ates, to determine whether the classes differed in the amount
willing to pay.
Covariate prevalence rates and 95% confidence intervals
were calculated for each latent class, and latent classes
were compared on the outcomes using multinomial logistic
regression analysis. Unlike traditional “classify then ana-
lyze” approaches that assume perfect classification, this
approach provides a test of statistical significance for differ-
ences between classes on the outcomes that takes into
account the posterior probabilities of class membership,
thus avoiding the assumption of perfect classification.
Results
LCA was conducted on participants with complete data on
demographic covariates (1,501 of the 1,535 participants;
97%). The sample was 50% female (n = 751) and the
majority (90%) was African American (n = 1362) and single
(79%, n = 1198). Nearly half (46%, n = 597) were between
the ages 13–20 (Table 1). Figure 1 highlights willingness to
take and buy HIVSTs, as well as the maximum price parti-
cipants were willing to pay for the HIVST. The majority
(90%, n = 1357) of the sample indicated that they would
be likely or very likely to take a free HIVST if it were
provided and 55% (n = 819) would be likely or very likely
to buy an HIVST. However, among those willing to test, only
23% (n = 228) of the sample indicated that they would be
willing to pay the estimated retail price of $40 for the test.
Nearly all (97%) reported they would be likely or very likely
to seek medical care if their test results were reactive.
A comparison of LCA model fit indices based on latent
class models with no covariates showed that a 4-class
solution was preferred (Table 2). The 4-class solution pro-
vided the lowest log likelihood and sample size adjusted
BIC, and entropy was good at 0.74. In addition, the LMR
test indicated a significant improvement in fit over a 3-class
model. Although the LMR suggested a significant improve-
ment in fit for the 5-class model over the 4-class model
(p = 0.046), the log likelihood and BIC values were higher
for the 5-class model, which was indicative of poorer fit for
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Table 1. Sample demographic characteristics (N = 1,535)
Variable N (%)
Female 751 (49.5)
African American 1362 (89.8)
Single 1198 (79.0)
Age
13–20 597 (45.5)
21–29 224 (17.1)
30–39 241 (18.4)
40 or older 249 (19.0)
Education
Less than high school 260 (17.1)
High school degree 765 (50.4)
At least some college education 492 (32.4)
Sexual orientation
Heterosexual 1357 (89.9)
Same-sex 64 (4.2)
Bisexual 88 (5.8)
Employed at least part time 712 (47.1)
Religious services attendance
Never 945 (62.3)
Sometimes 265 (17.5)
At least weekly 306 (20.2)
Has health insurance 932 (61.4)
Has a primary care physician 920 (60.7)
Table 2. Latent class analysis fit indices for latent class
models and class membership probabilities for 4 class model
with covariates and home HIV test outcomes
Model
Log
likelihood
(# of
parameters)
Sample
size
adjusted
BIC
Lo-Mendell-
Rubin
p-value for
k-1 classes Entropy
1 class −10053 (14) 20163 NA NA
2 classes −9424 (29) 18968 0.000 0.70
3 classes −9269 (44) 18720 0.188 0.75
4 classes −9155 (59) 18555 0.008 0.74
5 classes −9225 (74) 18756 0.046 0.76
6 classes −9207 (89) 18781 0.746 0.71
4 classes with
covariates
and self-HIV
test outcomes
−8874 (95) 18142 0.002 0.78
Most Likely Latent Class Membership Probabilities
Class 1 Class 2 Class 3 Class 4
Class 1 0.87 0.01 0.03 0.08
Class 2 0.01 0.88 0.04 0.08
Class 3 0.05 0.04 0.89 0.02
Class 4 0.05 0.07 0.01 0.88
Figure 1. Willingness to take HIVST and maximum price willing to pay for HIVST by latent class.
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the 5-class model. Consequently, we chose to interpret the
more parsimonious 4-class model. The average probability
of latent class membership was 0.87 for Class 1, 0.88 for
Class 2, 0.89 for Class 3 and 0.88 for Class 4, providing
additional support that the classes were distinct.
The 4-class model was then tested including the covari-
ates and the two HIVST outcomes. The BIC for this model
was lower than it was for the 4-class model with no cov-
ariates, suggesting an improvement in fit for the models
with the covariates and the outcomes. Entropy and average
latent class membership probabilities were improved as
well (Table 2). Estimated prevalence rates and confidence
intervals for the variables used to identify latent classes are
shown in Table 3.
Class 1: lower risk
Class 1 (N = 324, 21.6% of the entire sample) had the
lowest likelihood of having been tested for HIV among the
four classes. This class was least likely to perceive any risk
for acquiring HIV, with only 8% indicating they believed
they were at risk for HIV. Class 1 also had the fewest
number of recent sexual partners, with 96% indicating
that they had 0–1 partners in the past year. This class also
had the lowest likelihood of engaging in condomless sex
(42%), the lowest rate of participant (3%) and partner (8%)
concurrency, and relatively low rates of alcohol and other
drug use, ranging 2% for other drug use to 9.5% for using
alcohol at last sex. This class was labelled “Lower Risk”.
Class 2: concurrent sexual partnerships
Participants in Class 2 (N = 346, 23.0% of the entire sample)
were most likely to report engaging in condomless sex
(88%) and had the highest rate of participant (61%) and
partner (39%) concurrency. Although less likely to have a
history of incarceration compared to the third class, an
estimated 51% of participants in this class reported incar-
ceration histories; 22% reported using alcohol at last sex,
Table 3. Estimated percentages with 95% confidence intervals for LCA classification variables
Lower risk
(N = 324; 21.6%)
Concurrent
partnerships
(N = 346; 23.0%)
Incarceration/
substance use (N = 293;
19.5%)
Condomless sex/multiple
partners (N = 538; 35.8%)
Variable % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Perceived moderate or high risk for HIV 7.9 (2.7, 13.1) 31.8 (25.7, 37.8) 34.4 (27.1, 41.7) 20.8 (16.9, 24.7)
Ever tested for HIV 74.5 (68.4, 80.5) 91.0 (87.3, 94.7) 93.4 (90.1, 96.8) 84.8 (81.4, 88.3)
Ever incarcerated 15.2 (5.2, 25.2) 50.8 (43.3, 58.3) 77.4 (70.1, 83.8) 11.2 (7.0, 15.4)
Sexual behaviour
Engaged in condomless sex in past year 41.8 (32.1, 51.4) 88.2 (84.0, 92.5) 76.1 (69.9, 82.3) 78.7 (74.4, 83.0)
Engaged in risky sex ever* 5.0 (1.8, 8.3) 7.1 (3.7, 10.4) 35.8 (27.5, 44.1) 3.6 (1.5, 5.8)
Number of partners past year
0–1 96.4 (91.4, 100) 5.1 (0, 10.0) 47.2 (37.3, 57.2) 69.7 (63.0, 76.4)
2–5 3.4 (0, 8.3) 62.0 (55.4, 68.5) 37.1 (29.8, 44.4) 30.0 (23.9, 36.1)
6 or more <1.0 (0, 1.0) 32.9 (25.6, 40.2) 15.7 (9.8, 21.5) <1.0 (0, 1.8)
Participant had other partners during
most recent sexual relationship
3.3 (0, 6.1) 61.0 (51.6, 70.3) 38.4 (29.4, 47.4) 2.9 (0, 5.7)
Partner had other partners during
participant’s most recent sexual
relationship
No 70.9 (63.8, 78.0) 27.3 (20.1, 34.5) 38.6 (30.6, 46.6) 63.4 (58.1, 68.7)
Yes 8.4 (4.3, 12.5) 39.1 (31.9, 36.3) 31.8 (23.8, 39.8) 13.0 (9.3, 16.7)
Don’t know 20.7 (14.3, 27.0) 33.6 (27.8, 39.4) 29.6 (23.6, 35.6) 23.6 (19.3, 28.0)
Alcohol and other drug use
Binge drinking 3.1 (0, 7.3) 14.8 (9.7, 19.99) 28.8 (22.5, 53.2) 4.4 (2.1, 6.6)
Participant used alcohol at last sex 9.5 (2.3, 16.7) 21.8 (16.0, 27.6) 45.5 (38.4, 52.6) 6.6 (3.6, 9.6)
Cocaine/crack use ever 11.7 (5.1,18.3) <1.0 (0, 2.6) 74.9 (62.8, 87.0) 0.0 (0,0)
Other drug use ever 2.4 (0, 5.5) 15.5 (10.8, 20.1) 43.1 (34.2, 51.7) 3.0 (1.0, 4.9)
Note: * includes sex with some who was HIV positive, sex with someone who had an history of being an injection drug user, and sex in
exchange for things like drugs, alcohol, gifts, food, or shelter. Values in bold are defining characteristics of the latent classes. Dashes indicate
that the number endorsing that item was too small in one or both classes to get a reasonable parameter estimate.
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and 15% reported binge drinking and other drug use. This
class was labelled “Concurrent Sexual Partnerships”.
Class 3: incarceration and substance use
Class 3 participants (N = 293, 19.5% of the entire sample)
were the most likely to report having engaged in a higher-
risk sexual encounter (36%) and were most likely to have
been incarcerated (77%). Participants in this class had the
highest rate of alcohol and other drug use. An estimated
29% reported binge drinking, 45% used alcohol at last sex,
75% used cocaine and/or crack, and 43% reported other
drug use. Participants in this class were more likely than
Lower Risk and Condomless Sex/Multiple Partners class
participants to believe they were at risk for HIV (34%) and
to have been tested for HIV (93%). This class was labelled
“Incarceration and Substance Use”.
Class 4: condomless sex/multiple partners
Finally, the fourth and largest class (N = 538, 35.8% of the
entire sample) was somewhat similar to the Lower-Risk
class, with the exception that they were more likely to
engage in condomless sex (79%), more likely to report
having had 2–5 partners in the past year (30%), more likely
to believe they were at moderate-to-high risk of contract-
ing HIV (21%), and more likely to report having been tested
for HIV in the past (85%). This class was labelled
“Condomless Sex/Multiple Partners”.
Latent class differences in demographic
covariates
Table 4 shows prevalence rates in percentages for the
four classes on the demographic covariates, with 95%
confidence intervals. All participants in the Lower-Risk
class were at least thirty years old, with the majority
(96.6%) at least forty years old, which was significantly
older than the other three classes as evidenced by non-
overlapping confidence intervals. Compared to the other
three classes, the Lower-Risk class also had a significantly
greater percentage of heterosexual participants (96.3%),
participants attending religious services at least weekly
(33.3%), and had the lowest percentage of participants
Table 4. Estimated prevalence rates and 95% confidence intervals for demographic covariates
Variable
Lower risk%
(95% CI)
Concurrent partnerships
% (95% CI)
Incarceration and substance use
% (95% CI)
Condomless sex/multiple
partners % (95% CI)
Female 59.0 (53.4, 64.4) 21.1 (16.9, 25.8) 34.1 (28.7, 39.9) 70.8 (66.8, 74.6)
Age
13–20 0 (0.0, 0.0) 14.5 (10.9, 18.7) 0 (0.0, 0.0) 22.3 (18.9, 26.1)
21–29 0 (0.0, 0.0) 48.3 (42.9, 53.7) 8.2 (5.3, 11.9) 45.9 (41.6, 50.2)
30–39 3.4 (1.7, 6.0) 22.3 (18.0, 27.0) 16.7 (12.6, 21.5) 23.2 (19.7, 27.0)
40 or older 96.6 (94.0, 98.3) 15.0 (11.4, 19.2) 75.1 (69.7, 79.9) 8.6 (6.3, 11.2)
Education
Less than high school 14.2 (10.6, 18.5) 20.2 (16.1, 24.9) 29.4 (24.2, 34.9) 10.4 (7.6, 12.9)
High school degree 46.9 (50.7, 51.6) 58.7 (53.3, 63.9) 50.8 (45.0, 56.7) 48.8 (43.5, 52.1)
At least some college 39.8 (34.5, 45.4) 21.1 (16.9, 25.8) 19.8 (15.4, 24.8) 42.2 (38.0, 46.5)
Sexual orientation
Heterosexual 96.3 (93.6, 98.1) 88.4 (84.6, 91.6) 84.3 (79.6, 88.3) 90.3 (87.5, 92.7)
Same-sex 2.2 (0.9, 4.4) 4.1 (2.2, 6.8) 6.8 (4.2, 10.4) 4.3 (2.7, 6.4)
Bisexual 1.5 (0.5, 3.6) 7.5 (5.0, 10.8) 8.9 (6.8, 12.7) 5.4 (3.6, 7.7)
Employed at least
part time
46.0 (40.5, 51.6) 46.2 (40.9, 51.7) 29.4 (24.2, 34.9) 57.6 (53.3, 61.8)
Currently single 54.9 (49.3, 60.4) 90.1 (87.2, 93.6) 75.1 (69.7, 79.9) 88.3 (85.3, 90.1)
Attends religious
services
Never 46.6 (41.1, 52.2) 69.7 (64.5, 74.5) 63.1 (57.3, 68.7) 66.5 (62.4, 70.5)
Sometimes 20.1 (15.8, 24.8) 15.9 (12.2, 20.2) 14.7 (10.8, 19.3) 19.0 (15.7, 22.5)
At least weekly 33.3 (28.2, 38.8) 14.5 (10.9, 18.6) 22.2 (17.6, 27.4) 14.5 (11.6, 17.8)
Has health insurance 67.6 (62.2, 72.3) 49.4 (44.0, 54.8) 62.1 (56.3, 67.8) 64.9 (60.7, 68.9)
Has a primary care
physician
67.9 (62.5, 73.0) 45.1 (39.8, 50.5) 59.4 (53.5, 65.1) 66.9 (62.8, 70.1)
Note: Values in bold indicate significantly different percentages for each class compared to the other three classes as evidenced by non-
overlapping 95% confidence intervals.
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who were currently single (54.9%). The Concurrent
Partnerships class had significantly fewer women
(21.1%), and significantly fewer participants with health
insurance (49.4%) or a primary care physician (45.1%).
Compared to the other three classes, the Incarceration
and Substance Use class had a significantly lower percen-
tage of participants who were employed full time
(29.4%), and included a high percentage of men were.
Finally, the Condomless Sex/Multiple Partners class had a
significantly greater percentage of women (70.8%) and
had high percentages of individuals who had attended
some college, had health insurance, and a primary care
physician. In addition, this group had a significantly higher
percentage of participants between the age of 13–20
(22.3%), and have participants who were employed at
least part time (57.6%) compared to the other three
classes.
Latent class differences related to HIVST
variables
Figure 1 shows the unadjusted percentage of participants
in each class for the three HIVST outcomes. The
Concurrent Sexual Partnerships class had the highest per-
centage of participants who indicated they would be likely
to take an HIVST if it were free (94%), followed by the
Incarceration and Substance Use (92%) and Condomless
Sex/Multiple Partners (90%) classes. The Lower-Risk class
had the lowest percentage of participants who indicated
that they would likely take a free HIVST (84.9%), which
was significantly lower compared to the Concurrent Sexual
Partnerships class (OR = 0.39, p = 0.003) and the
Incarceration and Substance Use class (OR = 0.46,
p = 0.011) (see Table 5).
Among participants who indicated they would take a free
HIVST, 58% of members of the Concurrent Sexual
Partnerships and Condomless Sex/Multiple Partners classes
indicated they would be likely to buy an HIVST, followed by
50% of the Lower-Risk class and 47% of the Incarceration
and Substance Use classes. The Incarceration and
Substance Use class had a significantly lower proportion
of participants who would be willing to buy a home test
compared to the Concurrent Sexual Partnerships class
(OR = 0.66, p = 0.025) and the Condomless Sex/Multiple
Partners class (OR = 0.60, p = 0.002) (Table 5).
The majority of participants in all classes were willing to
pay $11–20 for an HIVST kit (Figure 1). There were no
significant differences between the classes in the amount
participants were willing to pay.
Discussion
HIVST was highly acceptable among participants in this
study. Participants were willing to take HIVSTs in an
urban, mostly African American US neighbourhood with
high rates of HIV infection and limited access to clinical
HIV screening and care services. Participants overwhel-
mingly reported that they would be willing to take an
HIVST, and that their friends, family and loved ones would
also be willing to self-test. In addition, LCA revealed four
distinct groups representing (1) lower-risk participants, (2)
participants with high rates of concurrent sexual partner-
ships, (3) participants with high rates of incarceration and
substance use, and (4) participants reporting condomless
sex and multiple sexual partnerships.
These classes had varying degrees of willingness to undergo
HIV self-testing. Compared to the other classes, the Lower-Risk
class was less willing to take a free HIVST. The incarceration and
substance use class was no less likely than the Concurrent
Sexual Partners Class or the Condomless Sex/Multiple
Partners class to be willing to take a free HIVST. However, the
Incarceration and Substance Use class was significantly less
willing to purchase an HIVST, despite being at potentially high
risk for acquiring HIV. Among participants who indicated that
they would be willing to purchase an HIVST, there were no
significant differences in the amount participants were willing
to pay across latent classes. This finding is particularly note-
worthy given that the overwhelming majority of participants
were of low socio-economic status and resided in urban neigh-
bourhoods with high levels of concentrated poverty and high
rates of HIV infection. Taken together, our findings highlight the
need to subsidize HIVSTs, lower HIVST prices, or provide HIVSTs
for free, particularly among individuals with a history of incar-
ceration or substance use.
Table 5. Odds ratios and 95% confidence intervals for differences between latent classes in HIVST outcomes
Variable
Lower risk vs.
concurrent
partnerships
OR (95%CI)
Lower risk vs.
incarceration/
substance use
OR (95%CI)
Lower risk vs.
condomless
sex/multiple
partners
OR (95%CI)
Concurrent
partnerships vs.
condomless sex/
multiple partners
OR (95% CI)
Incarceration/
substance use vs.
concurrent
partnerships
OR (95%CI)
Incarceration/
substance use vs.
condomless sex/
multiple partners
OR (95%CI)
Likely to take a
free HIVST
0.39 (0.21, 0.73) 0.46 (0.25, 0.84) 0.63 (0.37, 1.07) 0.62 (0.34, 1.14) 0.86 (0.44, 1.69) 0.68 (0.39, 1.20)
Likely to buy
HIVST
0.86 (0.60, 1.24) 1.30 (0.89, 1.96) 0.78 (0.55, 1.09) 1.11 (0.81, 1.53) 0.66 (0.46, 0.95) 0.60 (0.43, 0.82)
Note: Values in bold indicate significant differences between latent classes.
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This study adds empirical evidence to recent discussions
about uptake and acceptability of HIVST among individuals at
high risk for contracting HIV or in communities and neighbour-
hoods with high rates of infection [23–25]. In 2013,
Philadelphia had nearly 700 new HIV diagnoses, adding to
the total of nearly 20,000 people living with HIV in the city
[30]. Almost 28% of individuals diagnosed in 2011 were con-
currently diagnosed with AIDS [31] underscoring the need to
find approaches that decrease late entry into life-saving care.
Participants in this study overwhelmingly reported they would
seek medical care if their HIVSTs were reactive; self-testing
may therefore be an important means of reducing concurrent
HIV/AIDS diagnoses in urban neighbourhoods with high rates
of infection. Our high rates of acceptability also echo the
findings of other studies that underscored high levels of
acceptability of HIVST in other African American communities,
as well as among men who have sex with men [32–34].
In this Philadelphia community and elsewhere, access to
HIV screening and treatment are often compounded by other
broader social and structural challenges such as the presence
of high rates of poverty, joblessness and incarceration.
However, our findings suggest that the HIVST is highly accep-
table, but that individuals with a history or incarceration or
substance use may be less willing to purchase the HIVST. This
study provides important information about how best to
target HIVST education and outreach to those at highest risk
for HIV acquisition, including those with incarceration his-
tories, individuals with a history of substance use, individuals
engaging in condomless sex or sex with multiple partners and
those in concurrent sexual partnerships. HIVSTs could be
disseminated at reduced cost or for free at substance-use
treatment centres, upon discharge from prison or jail, and at
probation and parole offices.
Our findings also suggest that targeted messaging about HIV
risks and HIVSTs should be deployed according to the specific
characteristics associated with each latent class. For instance,
those in the condomless sex/multiple partnerships group were
more likely than others to be young and in between the ages of
13–20; this highlights opportunities to reduce HIV acquisition
risks by disseminating HIVSTs and messages about the risks of
engaging in condomless sex in collaboration with youth service
organizations in urban neighbourhoods. Similarly, those in the
concurrent partnerships class were less likely to have a primary
care physician or health insurance, highlighting opportunities to
promote HIVSTs and messages about the HIV risks associated
with having concurrent sexual partnerships in emergency
rooms, other places where uninsured individuals might seek
care (urgent care facilities), and health insurance linkage
programmes.
Limitations
This study is subject to several limitations. Future replication
of the analysis in independent samples would be useful to
determine whether the same profiles emerge reliably. When
we created the binary willingness to take and buy a home HIV
test outcomes, we chose to combine the “neutral” response
category with the “unlikely and very unlikely” response cate-
gories in order to clearly test hypotheses about willingness to
test. By doing so, it is possible that we underestimated will-
ingness to take or buy the test because many participants
whose beliefs were neutral may become more willing to take
or buy the test in the future. Additionally, we did not admin-
ister HIVSTs as part of this study; we were therefore unable to
determine whether some of the responses reflected social
desirability bias, or whether people with reactive self-test
results would seek appropriate medical services or be
retained in HIV care. Moreover, respondents in this study
had already agreed to undergo testing as part of our large-
scale screening and care programme; these participants may
therefore not necessarily be representative of the broader
community where this study was conducted, some of whom
may have self-selected to not participate in this study.
Conclusions
Our findings highlight important public health opportunities for
expanding access to HIVSTs among individuals at high risk for
contracting HIV in a community with high rates of infection and
limited access to HIV screening and care services. The LCA
method also aided in identifying, in an era of scarce resources,
individuals at high risk who are willing to take HIVSTs but who
may be unable or unwilling to pay themarket rate for an HIVST.
The results of this study also provided useful information that
could inform dissemination of HIVST efforts that are tailored to
the characteristics of each specific latent class, particularly
among individuals with incarceration histories and those
reporting condomless sex with multiple partners. Future pro-
grammes should explore how best to deliver and reduce costs
of HIVST technology inmedically underserved communities and
among populations at highest risk for contracting HIV.
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